The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Drug maker GlaxoSmithKline, along with the Food and Drug Administration, warned doctors that the antidepressant Paxil may raise the risk of suicidal behavior in young adults. The warning letter was accompanied by changes to the labeling of both Paxil and Paxil CR, a controlled-release version of the drug, also called paroxetine

.

Comments are closed.

Of Interest